Merrimack Pharmaceuticals Inc (MACK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -40,506 | 470,868 | -153,518 | -147,787 | -83,559 |
| Depreciation Amortization | 3,423 | 5,221 | 4,895 | 3,250 | 3,223 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | 712 |
| Accounts receivable | 100 | 175 | -264 | 1,654 | 2,587 |
| Accounts payable and accrued liabilities | -3,801 | -9,278 | -9,837 | 13,163 | -646 |
| Other Working Capital | -6,956 | -19,600 | -7,509 | 17,159 | 23,108 |
| Other Operating Activity | -17,848 | -573,197 | -4,008 | 7,205 | 19,767 |
| Operating Cash Flow | $-65,588 | $-125,811 | $-170,241 | $-105,356 | $-34,808 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -50,555 | 0 | -102 | 87,899 | 26 |
| PPE Investments | -43 | 179 | -2,640 | -11,902 | -6,035 |
| Net Acquisitions | 28,000 | 580,714 | N/A | N/A | N/A |
| Other Investing Activity | 0 | -4,002 | -515 | -887 | -2 |
| Investing Cash Flow | $-22,598 | $576,891 | $-3,257 | $75,110 | $-6,011 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 14,632 | 0 | N/A | 169,434 | 0 |
| Debt Repayment | 0 | -229,662 | N/A | -40,000 | 0 |
| Common Stock Issued | 0 | 6,917 | 6,224 | 48,647 | 10,384 |
| Dividend Paid | N/A | -140,000 | N/A | N/A | N/A |
| Other Financing Activity | 0 | -16,418 | 3,192 | 2,083 | 1,037 |
| Financing Cash Flow | $14,632 | $-379,163 | $9,416 | $180,164 | $11,421 |
| Beginning Cash Position | 94,217 | 22,300 | 185,606 | 35,688 | 65,086 |
| End Cash Position | 20,663 | 94,217 | 21,524 | 185,606 | 35,688 |
| Net Cash Flow | $-73,554 | $71,917 | $-164,082 | $149,918 | $-29,398 |
| Free Cash Flow | |||||
| Operating Cash Flow | -65,588 | -125,811 | -170,241 | -105,356 | -34,808 |
| Capital Expenditure | -118 | -915 | -2,640 | -11,902 | -6,035 |
| Free Cash Flow | -65,706 | -126,726 | -172,881 | -117,258 | -40,843 |